National Comprehensive Cancer Network
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025
Abstract
The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of NSCLC. These NCCN Guidelines Insights discuss recent updates to the NCCN Guidelines, with a focus on systemic therapy options for the treatment of patients with nonmetastatic NSCLC and the corresponding molecular testing considerations.
Source and rights
Published by Journal of the National Comprehensive Cancer Network : JNCCN, 2025. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- National Comprehensive Cancer Network
- Published
- 2025
- Applies to
- 🇺🇸 United States
- Scope
- National
- Journal
- Journal of the National Comprehensive Cancer Network : JNCCN
- PubMed
- 40930154
- Added to Prognia
- 18 July 2026
More in oncology
- Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyNational Comprehensive Cancer Network · 2026
- Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)Research Excellence, Active Leadership Canadian Breast Cancer Alliance (REAL Alliance) [2] · 2026
